Belharra Therapeutics
PrivateLast Round
Series A
Jan 4, 2023
Total Funding Raised
$50M
Company Overview
Belharra Therapeutics is a biotechnology company that develops a photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously undruggable protein targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Belharra Therapeutics Comparables
Compare Belharra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BridGene Biosciences | 89% | |
| Nexo Therapeutics | 83% | |
| Frontier Medicines | 82% |
Belharra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 4, 2023 |
Belharra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2025
Sean Buchanan appointed as Chief Scientific Officer.
- Jan 4, 2023
$50M round led by Versant Ventures
Belharra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Belharra Therapeutics's valuation, stock price, and market status.
Is Belharra a public or private company?
Belharra is a private company.
What is the current stock price of Belharra?
Belharra is a private company with no public stock price. No recent secondary market data is available.
How much is Belharra worth (valuation)?
Valuation information for Belharra is not publicly available.
Can I buy Belharra stock?
Belharra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Belharra's last funding round?
Belharra's most recent funding round was Series A on January 4, 2023.
Who are the main investors in Belharra?
Key investors in Belharra include Versant Ventures.
Will Belharra IPO soon?
No public IPO plans have been announced for Belharra.
How can I track Belharra secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Belharra's secondary market activity and sign up for updates.